Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study.

Study findings indicate that the T allele of IGF1R variant rs2016347 is associated with a significant reduction in breast cancer risk in women with a history of preeclampsia, most marked for HR+ breast cancer and in women with AFB < 30.